A new glycan biomarker for pancreatic cancer complements CA19-9 and identifies a distinct subpopulation of cancer cells

被引：0
|
作者：
Barnett, Daniel
Liu, Ying
Partyka, Katie
Hostetter, Galen
Zeh, Herbert
Singhi, Aatur D.
Huang, Ying
Drake, Richard R.
Brand, Randall E.
Haab, Brian B.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1754
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1754
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pancreatic cancer serum biomarker PC-594:Diagnostic performance and comparison to CA19-9
    Shawn A Ritchie
    Bassirou Chitou
    Qingan Zheng
    Dushmanthi Jayasinghe
    Wei Jin
    Asuka Mochizuki
    Dayan B Goodenowe
    World Journal of Gastroenterology, 2015, (21) : 6604 - 6612
  • [22] CA19-9 as a Prognostic Biomarker in Pancreatic Neuroendocrine Tumors
    Luo, G.
    Guo, M.
    Liu, Z.
    Liu, C.
    Cheng, H.
    Lu, Y.
    Jin, K.
    Zhang, B.
    Liu, L.
    Long, J.
    Xu, J.
    Ni, Q.
    Chen, J.
    Yu, X.
    NEUROENDOCRINOLOGY, 2016, 103 : 49 - 49
  • [23] Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer
    Asaoka, Tadafumi
    Miyamoto, Atsushi
    Maeda, Sakae
    Tsujie, Masanori
    Hama, Naoki
    Yamamoto, Kazuyoshi
    Miyake, Masakazu
    Haraguchi, Naotsugu
    Nishikawa, Kazuhiro
    Hirao, Motohiro
    Ikeda, Masataka
    Sekimoto, Mitsugu
    Nakamori, Shoji
    PANCREATOLOGY, 2016, 16 (03) : 434 - 440
  • [24] The Value of CA19-9 After Irreversible Electroporation for Pancreatic Cancer
    Mansson, Christopher
    Nilsson, Anders
    Urdzik, Jozef
    Karlson, Britt-Marie
    ANTICANCER RESEARCH, 2019, 39 (11) : 6193 - 6196
  • [25] Glycan CA19-9 mediated immune modulation in the pancreatic tumor microenvironment
    Hsu, Jasper
    Oh, Tae Gyu
    Peck, Kristina L.
    Rock, Angelica E.
    Bishop, Garret
    Okhovat, Shira R.
    Kaech, Susan M.
    Engle, Dannielle D.
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Serum level of TSGF,CA242 and CA19-9 in pancreatic cancer
    Jing-Ting Jiang Chang-Ping Wu Hai-Feng Deng Ming-Yang Lu Jun Wu Hong-Yu Zhang Wen-Hui Sun Mei Ji Department of Tumor Biological Treatment
    World Journal of Gastroenterology, 2004, (11) : 1675 - 1677
  • [27] CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
    Guopei Luo
    Zhiwen Xiao
    Jiang Long
    Zuqiang Liu
    Liang Liu
    Chen Liu
    Jin Xu
    Quanxing Ni
    Xianjun Yu
    Journal of Gastrointestinal Surgery, 2013, 17 : 2092 - 2098
  • [28] CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer
    Luo, Guopei
    Xiao, Zhiwen
    Long, Jiang
    Liu, Zuqiang
    Liu, Liang
    Liu, Chen
    Xu, Jin
    Ni, Quanxing
    Yu, Xianjun
    JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (12) : 2092 - 2098
  • [29] Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer
    Jiang, Jing-Ting
    Wu, Chang-Ping
    Deng, Hai-Feng
    Lu, Ming-Yang
    Wu, Jun
    Zhang, Hong-Yu
    Sun, Wen-Hui
    Ji, Mei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (11) : 1675 - 1677
  • [30] Perioperative CA19-9 in Potentially Resectable Pancreatic Cancer: New Perspectives to Individualize Therapy
    Hartwig, W.
    Strobel, O.
    Hinz, U.
    Fritz, S.
    Hackert, T.
    Roth, C.
    Buechler, M. W.
    Werner, J.
    PANCREAS, 2012, 41 (08) : 1365 - 1365
12345